Placeholder

The toll of terror

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1561.

Product Description

VIEW on Sept. 11  

2001 was never going to be a stellar year for global economies, but until September 11, 2001, many in the business world predicted a quick recovery. Those hopes have faded somewhat as consumer spending, rising unemployment, and business uncertainty plague some sectors. The bio-pharmaceutical industry will emerge relatively unscathed compared with other industrial sectors, however, there will be a noteworthy impact on key budget and policy initiatives, according to Dr. Ken LaPensee, senior VP, Cambridge Pharma Consultancy. Cambridge Pharma Consultancy, with corporate offices in New York and Cambridge, England, is a leading international firm specializing in the pharmaceutical…

Sidebar:
Cambridge Pharma reports …

Expert on this topic
Dr. Ken LaPensee
, Senior VP, Cambridge Pharma Consultancy

FEEDBACK